Thalamus Seizure Detection With a Deep Brain Stimulator System

Recruiting N/A Interventional Study
Epilepsy; Seizure
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Basic Science
Participants needed
5 (estimated)
Sponsor
Mayo Clinic · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The purpose of this study is to determine the feasibility of chronic ambulatory thalamus seizure detection. The sensitivity, specificity, and false alarm rate of thalamus seizure detection will be calculated using recordings from a deep brain stimulation system, assessed relative to concurrent gold-standard video-EEG monitoring collected in the in-patient setting (epilepsy monitoring unit), in 5 p…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Participants must meet all of the inclusion criteria to participate in this study: * 18 years of age and older. * Implanted with a clinical DBS system for epilepsy with brain recording capabilities (Medtronic Percept™ DBS). * Subject or legally authorized representative is able…
Contacts

Karla Crockett

507-538-4880

crockett.karla@mayo.edu

CONTACT